CD274 and neoplasm: This issue is confounded by multiple unresolved problems: variable detection antibodies, differing IHC cut-off values, tissue preparation, processing variabilities, primary versus metastatic biopsies, oncogenic versus induced PD-L1 expression and staining of tumour versus immune cells [81,82].